Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10038074HBVENSG00000165646.14protein_codingSLC18A2NoNo6571Q05940
TVIS10046857HBVENSG00000165646.14protein_codingSLC18A2NoNo6571Q05940
TCGA Plot Options
Drug Information
GeneSLC18A2
DrugBank IDDB04844
Drug NameTetrabenazine
Target IDBE0000118
UniProt IDQ05940
Regulation Typeinhibitor
PubMed IDs17233532; 11752352; 19571144; 19223416; 20007701; 20135628
CitationsZheng G, Dwoskin LP, Crooks PA: Vesicular monoamine transporter 2: role as a novel target for drug development. AAPS J. 2006 Nov 10;8(4):E682-92.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Kim YS, Shin JH, Hall FS, Linden DJ: Dopamine signaling is required for depolarization-induced slow current in cerebellar Purkinje cells. J Neurosci. 2009 Jul 1;29(26):8530-8. doi: 10.1523/JNEUROSCI.0468-09.2009.@@Goland R, Freeby M, Parsey R, Saisho Y, Kumar D, Simpson N, Hirsch J, Prince M, Maffei A, Mann JJ, Butler PC, Van Heertum R, Leibel RL, Ichise M, Harris PE: 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med. 2009 Mar;50(3):382-9. doi: 10.2967/jnumed.108.054866. Epub 2009 Feb 17.@@Gros Y, Schuldiner S: Directed evolution reveals hidden properties of VMAT, a neurotransmitter transporter. J Biol Chem. 2010 Feb 12;285(7):5076-84. doi: 10.1074/jbc.M109.081216. Epub 2009 Dec 10.@@Wimalasena K: Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry. Med Res Rev. 2011 Jul;31(4):483-519. doi: 10.1002/med.20187. Epub 2010 Feb 4.
GroupsApproved; Investigational
Direct ClassificationTetrahydroisoquinolines
SMILESCOC1=C(OC)C=C2C3CC(=O)C(CC(C)C)CN3CCC2=C1
Pathways
PharmGKBPA140222719
ChEMBLCHEMBL117785